{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:48:01Z","timestamp":1762098481297,"version":"3.40.5"},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ajconline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.amjcard.2014.10.038","type":"journal-article","created":{"date-parts":[[2014,11,10]],"date-time":"2014-11-10T22:19:36Z","timestamp":1415657976000},"page":"298-302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Long-Term Outcome of Sirolimus-Eluting and Zotarolimus-Eluting Coronary Stent Implantation in Patients With and Without Diabetes Mellitus (A Danish Organization for Randomized Trials on Clinical Outcome III Substudy)"],"prefix":"10.1016","volume":"115","author":[{"given":"Kevin K.W.","family":"Olesen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Henrik","family":"Tilsted","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisette O.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Kaltoft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars R.","family":"Krusell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Ravkilde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evald H.","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Thayssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik T.","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens F.","family":"Lassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4310-6433","authenticated-orcid":false,"given":"Michael","family":"Maeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2014.10.038_bib1","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.amjcard.2011.06.037","article-title":"Outcome of sirolimus-eluting versus zotarolimus-eluting coronary stent implantation in patients with and without diabetes mellitus (a SORT OUT III Substudy)","volume":"108","author":"Maeng","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2014.10.038_bib2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/CIRCINTERVENTIONS.110.959924","article-title":"Novel approaches for preventing or limiting events in diabetic patients (Naples-diabetes) trial: a randomized comparison of 3 drug-eluting stents in diabetic patients","volume":"4","author":"Briguori","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2014.10.038_bib3","doi-asserted-by":"crossref","first-page":"e5170","DOI":"10.1136\/bmj.e5170","article-title":"Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials","volume":"345","author":"Bangalore","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.amjcard.2014.10.038_bib4","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jcin.2012.04.008","article-title":"3-Year clinical outcomes in the randomized SORT OUT III superiority trial comparing zotarolimus- and sirolimus-eluting coronary stents","volume":"5","author":"Maeng","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2014.10.038_bib5","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0140-6736(10)60208-5","article-title":"Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial","volume":"375","author":"Rasmussen","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2014.10.038_bib6","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(14)60405-0","article-title":"Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trial","volume":"383","author":"Maeng","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2014.10.038_bib7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4244\/EIJV7I3A56","article-title":"Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial","volume":"7","author":"Jensen","year":"2011","journal-title":"EuroIntervention"},{"key":"10.1016\/j.amjcard.2014.10.038_bib8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jcin.2012.12.123","article-title":"The \u201cfinal\u201d 5-year follow-up from the ENDEAVOR IV trial comparing a zotarolimus-eluting stent with a paclitaxel-eluting stent","volume":"6","author":"Kirtane","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2014.10.038_bib9","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2014.10.038_bib10","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.amjcard.2012.07.022","article-title":"Comparison of outcomes in patients with versus without diabetes mellitus after revascularization with everolimus- and sirolimus-eluting stents (from the SORT OUT IV trial)","volume":"110","author":"Jensen","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2014.10.038_bib11","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/ccd.25045","article-title":"Long-term efficacy and safety of Zotarolimus-eluting stent in patients with diabetes mellitus: pooled 5-year results from the ENDEAVOR III and IV trials","volume":"82","author":"Vardi","year":"2013","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2014.10.038_bib12","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.jacc.2008.07.006","article-title":"Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study","volume":"52","author":"Wenaweser","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2014.10.038_bib13","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1016\/j.jacc.2010.03.020","article-title":"2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents","volume":"55","author":"Byrne","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2014.10.038_bib14","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/eurheartj\/ehp044","article-title":"A\u00a0polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents","volume":"30","author":"Byrne","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2014.10.038_bib15","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jcin.2010.12.014","volume":"4","author":"Kandzari","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2014.10.038_bib16","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1093\/eurheartj\/ehu318","article-title":"Endeavour zotarolimus-eluting stent reduces stent thrombosis and improves clinical outcomes compared with cypher sirolimus-eluting stent: 4 year results of the PROTECT randomized trial","volume":"35","author":"Wijns","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2014.10.038_bib17","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(12)60324-9","article-title":"Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis","volume":"379","author":"Palmerini","year":"2012","journal-title":"Lancet"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914914020700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914914020700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T17:51:37Z","timestamp":1538070697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914914020700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0002914914020700"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2014.10.038","relation":{},"ISSN":["0002-9149"],"issn-type":[{"type":"print","value":"0002-9149"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Outcome of Sirolimus-Eluting and Zotarolimus-Eluting Coronary Stent Implantation in Patients With and Without Diabetes Mellitus (A Danish Organization for Randomized Trials on Clinical Outcome III Substudy)","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2014.10.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}